|
⚲
|
| Keyboard |
| ProQuest Associates IV LLC
✚
|
|
|---|---|
| CIK # | 0001431819 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| UroGen Pharma Ltd | 37.3 | ||
| Holdings by Sector ($M) |
|---|
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001431819] | |
| 3 | [0001431819] | |
| 4 | [0001431819] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
UroGen Pharma Ltd URGN
Ordinary Shares, par value NIS 0.01 per share
|
2017-11-28 | Sell | 177,807 | $40.51 | 7,202,962 |
|
UroGen Pharma Ltd URGN
Ordinary Shares, par value NIS 0.01 per share
|
2017-11-27 | Sell | 31,491 | $41.12 | 1,294,910 |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock $0.001 par value
|
2017-05-15 | Other | 149,107 | $0.00 | |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock $0.001 par value
|
2017-05-15 | Other | 149,107 | $0.00 | |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock $0.001 par value
|
2017-05-15 | Other | 3,584,087 | $0.00 | |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock $0.001 par value
|
2017-04-25 | Option exercise | 10,000 | $46.09 | 460,900 |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock $0.001 par value
|
2017-04-25 | Option exercise | 2,340 | $8.78 | 20,545 |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock $0.001 par value
|
2017-04-25 | Option exercise | 2,340 | $8.78 | 20,545 |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock $0.001 par value
|
2017-04-25 | Option exercise | 2,340 | $4.04 | 9,454 |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock $0.001 par value
|
2017-04-25 | Option exercise | 2,340 | $0.90 | 2,106 |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock $0.001 par value
|
2017-04-25 | Sell | 51,219 | $88.34 | 4,524,686 |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock $0.001 par value
|
2017-04-25 | Option exercise | 2,340 | $8.78 | 20,545 |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock $0.001 par value
|
2017-04-25 | Option exercise | 20,000 | $59.31 | 1,186,200 |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock $0.001 par value
|
2017-04-25 | Option exercise | 3,120 | $4.42 | 13,790 |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock $0.001 par value
|
2017-04-25 | Option exercise | 9,360 | $12.67 | 118,591 |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock $0.001 par value
|
2017-04-25 | Sell | 2,961 | $89.09 | 263,795 |
|
Eagle Pharmaceuticals Inc EGRX
Stock Option (right to buy) · derivative
|
2017-04-25 | Option exercise | 2,340 | $0.00 | |
|
Eagle Pharmaceuticals Inc EGRX
Stock Option (right to buy) · derivative
|
2017-04-25 | Option exercise | 2,340 | $0.00 | |
|
Eagle Pharmaceuticals Inc EGRX
Stock Option (right to buy) · derivative
|
2017-04-25 | Option exercise | 20,000 | $0.00 | |
|
Eagle Pharmaceuticals Inc EGRX
Stock Option (right to buy) · derivative
|
2017-04-25 | Option exercise | 2,340 | $0.00 | |
| showing 20 of 181 most recent transactions | |||||